Esketamine Combined With Magnesium Sulfate for Postoperative Fatigue Syndrome in Patients Undergoing Laparoscopic Cholecystectomy

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 6, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2025

Conditions
Laparoscopic CholecystectomyAlleviate Postoperative Fatigue Syndrome
Interventions
DRUG

Esketamine

Patients were given intravenous esketamine 0.25 mg/kg 10 min before induction of anaesthesia, followed by continuous pumping at 0.25 mg/(kg-h) until the end of the operation.

DRUG

Magnesium sulfate

Patients were injected with 30 mg/kg of magnesium sulphate intravenously 10 min before the induction of anaesthesia, followed by continuous pumping at 10 mg/(kg-h) until the end of the operation.

DRUG

Esketamine and Magnesium sulfate

Patients received a simultaneous intravenous infusion of esketamine (0.25 mg/kg) and magnesium sulfate (30 mg/kg) over 10 minutes before anesthesia induction, followed by continuous infusion of esketamine at 0.25 mg/kg/h and magnesium sulfate at 10 mg/kg/h via separate channels until surgery completion.

DRUG

Saline

Patients in the control group received an equivalent volume of normal saline infused intravenously over 10 minutes before anesthesia induction, followed by continuous saline infusion at a matched flow rate via a separate channel until surgery completion.

Trial Locations (1)

Unknown

The Affiliated Huaian Hospital of Xuzhou Medical University, Huai'an Second Hospital, Huaian

All Listed Sponsors
lead

The Second People's Hospital of Huai'an

OTHER

NCT07131033 - Esketamine Combined With Magnesium Sulfate for Postoperative Fatigue Syndrome in Patients Undergoing Laparoscopic Cholecystectomy | Biotech Hunter | Biotech Hunter